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Concussion is a form of traumatic brain injury (TBI) that presents with a wide spectrum 
of subjective symptoms and few objective clinical findings. Emerging research suggests 
that one of the processes that may contribute to concussion pathophysiology is dysreg-
ulation of cerebral blood flow (CBF) leading to a mismatch between CBF delivery and 
the metabolic needs of the injured brain. Cerebrovascular reactivity (CVR) is defined as 
the change in CBF in response to a measured vasoactive stimulus. Several magnetic 
resonance imaging (MRI) techniques can be used as a surrogate measure of CBF in 
clinical and laboratory studies. In order to provide an accurate assessment of CVR, these 
sequences must be combined with a reliable, reproducible vasoactive stimulus that can 
manipulate CBF. Although CVR imaging currently plays a crucial role in the diagnosis 
and management of many cerebrovascular diseases, only recently have studies begun 
to apply this assessment tool in patients with concussion. In order to evaluate the quality, 
reliability, and relevance of CVR studies in concussion, it is important that clinicians and 
researchers have a strong foundational understanding of the role of CBF regulation in 
health, concussion, and more severe forms of TBI, and an awareness of the advantages 
and limitations of currently available CVR measurement techniques. Accordingly, in this 
review, we (1) discuss the role of CVR in TBI and concussion, (2) examine methodolog-
ical considerations for MRI-based measurement of CVR, and (3) provide an overview of 
published CVR studies in concussion patients.
Keywords: concussion, cerebrovascular reactivity, magnetic resonance imaging, blood oxygen 
level-dependent imaging, carbon dioxide
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BaCKGroUnd
Traumatic brain injury (TBI) continues to be one of the leading 
causes of death and disability among young people worldwide. 
The pathophysiology of TBI is characterized by a primary injury 
that results in structural injury to the brain, followed by a sec-
ondary injury that is caused by a combination of inflammation, 
edema, ischemia, cellular necrosis, and apoptosis (1). Some of 
these mechanisms are readily detectable on clinical neuroimaging 
studies in mild, moderate, and severe TBI patients; with the pres-
ence of certain features highly correlated with patient outcome 
(2, 3). Although mTBI and concussion are terms that are often 
used interchangeably to describe patients with similar clinical 
presentations, concussion is thought to represent a form of mTBI 
that typically occurs in the absence of structural brain injury (4). 
Consequently, clinical neuroimaging studies are normal in the 
vast majority of patients (5), and the clinical manifestations of this 
condition are proposed to be mediated by neuronal dysfunction 
and cerebrovascular dysregulation (6, 7).
Among the most important factors responsible for maintaining 
brain function during health and injury is the process of matching 
cerebral blood flow (CBF) to the metabolic needs of the brain. 
In the setting of TBI, periods of mismatched CBF can result in 
secondary brain injury that can impact patient outcomes (8–11). 
Cerebrovascular reactivity (CVR), defined as the change in CBF 
in response to a vasoactive stimulus, is a means to interrogate the 
integrity of the effector arm of the demand–supply control of CBF. 
To measure CVR among patients with cerebrovascular disease 
including stroke, TBI, and concussion, research studies have 
combined the use of several advanced non-invasive neuroimag-
ing techniques with several types of vasoactive stimuli. While the 
neuroimaging techniques used to assess CBF in these studies are 
highly reliable and reproducible, the vasoactive stimuli used to 
manipulate CBF are not (12). Several studies have examined CVR 
in patients with moderate and severe TBI (11, 13), however, only 
recently have studies examining CVR in patients with concussion 
become available (14–17). It is therefore important for clinicians 
and researchers interested in the role of CBF regulation in the 
pathophysiology of concussion to be able to evaluate the quality, 
reliability, and implications of studies performed in this population.
Accordingly, the objectives of the present review were three-
fold: (1) to discuss the role of cerebrovascular physiology in the 
health and the injured brain including the concussed brain, (2) to 
review the role and limitations of MRI-based tools and vasoactive 
stimuli used to measure CVR, and (3) to provide an overview of 
published CVR studies in concussion patients.
CereBraL BLood FLoW 
reGULation, CereBroVasCULar 
reaCtiVity, and traUMatiC Brain 
inJUry
Cerebral Blood Flow regulation and 
Cerebrovascular reactivity
Although the brain accounts for only 2% of total body weight, 
it receives 15–20% of the cardiac output in humans. In order to 
maintain the health of this essential organ, the cerebral vascu-
lature must maintain CBF within precise limits under a wide 
spectrum of states during rest, activity, and disease. Control of 
CBF is achieved primarily by altering the flow resistance within 
the cerebral blood vessels at the arteriolar level. In a more global 
sense, CBF is dependent on the cerebral perfusion pressure 
(CPP), which is influenced by the mean arterial blood pressure 
(MAP), the intracranial pressure (ICP), and the resistance of the 
major arteries. However, on a regional scale, in order to meet the 
increased energy demands of the brain during activation or dis-
ease, the cerebral vasculature must respond appropriately to more 
localized physiological stimuli, which include the direct action of 
signaling messengers such as calcium ions, nitric oxide, acetyl-
choline, vasoactive intestinal polypeptide (VIP), calcitonin gene-
related peptide (CGRP), substance P, prostaglandins, and other 
arachadonic acid metabolites released by astrocytes and neurons 
as well as local factors such as intraluminal hydrostatic pressure, 
pH, and partial pressure of arterial carbon dioxide (PaCO2) and 
oxygen (PaO2) (18) (see Figure  1). Laboratory evidence also 
suggests that capillary pericytes respond to similar physiologi-
cal stimuli and play an important role in CBF regulation during 
neuronal activation and ischemia at the micro-regional level (19). 
Failure to appropriately match CBF with surges in the metabolic 
demands of the brain can lead to temporary or permanent 
alterations in neurological functioning. This strong dependence 
is accomplished by a process known as neurovascular coupling, 
whereby increases in neuronal activity, and consequently, the 
cerebral metabolic rate of oxygen (CMRO2) is tightly related to 
corresponding increases in regional CBF. Modulation of CBF 
during neuronal activity requires the coordinated efforts of the 
neurovascular unit, which includes neurons, astrocytes, peri-
cytes, microglia, and the vascular endothelial and smooth muscle 
cells (20), and typically results in an “overshoot” in blood flow 
with respect to O2 demand, thereby delivering more oxygen than 
is consumed by the active assembly of neurons. It has therefore 
been postulated that this functional hyperemia is required for the 
delivery of other substrates such as glucose, or the removal of 
metabolic waste or heat. Acute or chronic insufficiency in CBF 
delivery can exist along a continuum resulting in a wide spectrum 
of disease conditions including transient ischemic attack (TIA), 
acute ischemic stroke, and vascular dementia (21). One of the 
ways to assess the functional integrity of this complex regulatory 
system is to measure the brain’s cerebrovascular response to a 
vasoactive stress or stimulus. A vasoactive stimulus is a stimulus 
that can be applied to the brain and produces a quantifiable and 
reliable effect on the cerebral vasculature, usually stimulating 
vasodilation.
In general, the effect of any vasodilatory stimulus on any vas-
cular bed in the brain is dependent on (1) the magnitude of the 
vasodilatory stimulus; (2) the difference in vasodilatory reserve of 
the interrogated vascular bed and that of the beds with which it is 
perfused in parallel; and (3) the flow reserve of the feeding vessel 
to both beds (22) (Figure 2A). Therefore, with intact vasodila-
tory reserves, the application of a global vasodilatory stimulus 
like hypercapnia, will produce a balanced reduction in vascular 
tones and a symmetrical increase in CBF in all beds (Figure 2B). 
However, if the vasodilatory reserve of a particular vascular bed 
FiGUre 1 | General schema of cerebral perfusion. Intracranial vessels are perfused in parallel in a fractal branching pattern. The net flow in each region is 
dynamically determined by the net flow resistance of each branch. Under normal conditions, the inflow from major extracranial vessels is not limiting. The flow to 
each vascular region is controlled by its local factors as shown in the figure. The net effect of regional vascular resistances determines the total cerebral blood flow. 
However, with a strong global vasodilatory stimulus, the drop in resistance in the collective downstream branches can be reduced to the point where the blood flow 
in the larger supply vessels is limiting (“fixed minimal resistance” in supply vessel in the figure). Abbreviation: CPP, cerebral perfusion pressure; MAP, mean arterial 
pressure; ICP, intracranial pressure; PaCO2, arterial partial pressure of carbon dioxide; PaO2, arterial partial pressure of oxygen; Ca++, calcium ions; ACh, 
acetylcholine; VIP, vasoactive intestinal polypeptide; PGE, prostaglandins.
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is compromised, the application of a vasodilatory stimulus will 
result in an asymmetrical vasodilatory response (Figure  2C). 
When there is adequate inflow reserve, the changes in flow to 
each vascular bed follows its change in resistance. When the total 
flow demand of the beds exceeds the inflow capability, a condition 
to which the brain vasculature is uniquely susceptible (23), there 
is a redistribution of blood flow in favor of the vascular bed with 
better vasodilatory reserve. In severe cases where vasodilatory 
reserve is diminished or abolished in a vascular bed, the flow 
becomes completely dependent on the perfusion pressure and on 
the relative changes in resistance of the vascular beds with intact 
vasodilatory reserve that are perfused in parallel. Therefore, 
even in the setting of normal global mean CBF, regional impair-
ments in the control of vascular resistance can lead to regional 
hypo- and hyperperfusion (see Figure 2C). This mechanism can 
apply to vessels that range in scale from capillaries to cerebral 
arteries and even extracranial arteries (24). Such cerebrovascular 
dysregulation may be unmasked by applying a global vasodila-
tory stimulus to the cerebral vasculature and observing changes 
in regional CBF.
While these concepts are easy to understand, they are some-
what difficult to apply in practice. Indeed, CVR varies consid-
erably even among healthy subjects (25) and within a healthy 
subject over time (26). That CVR normally varies considerably 
between brain regions and between white matter and gray matter 
makes accurate assessment and interpretation of CVR studies 
challenging (27–30). Within these regions, sustained hypoperfu-
sion or the inability to adequately respond to metabolic demand 
surges (as detected by CVR) can lead to local brain dysfunction 
(31) and structural degeneration (32). Furthermore, impairments 
in CVR have been associated with numerous cerebrovascular 
diseases such as intra- and extracranial steno-occlusive disease 
(33–37), arteriovenous malformations (38), cerebral proliferative 
angiopathy (39), and cerebral vasospasm following aneurysmal 
subarachnoid hemorrhage (40) and are strongly predictive of the 
development of ischemic stroke (41–43). Given the enormous 
increases in energy requirements associated with TBI, the 
adequacy of the cerebrovascular response to match CBF supply to 
the metabolic demands of the injured brain is likely an important 
consideration impacting clinical deficits and injury recovery.
Cerebrovascular disturbances in tBi
The pathophysiology of TBI is characterized by primary and 
secondary brain injury. Primary brain injury refers to the direct 
biomechanical disruption of brain tissue that occurs at the time 
of initial impact and which can range from focal injuries such as 
parenchymal contusions and subdural hematoma to more global 
injuries such as diffuse axonal injury (DAI). While these processes 
account for a significant proportion of the morbidity and mor-
tality associated with moderate and severe TBI, these processes 
are not thought to play a prominent role in the pathophysiology 
of concussion (4). On the other hand, secondary brain injury 
is characterized by a combination of cellular, metabolic, and 
inflammatory processes that can result in further tissue edema, 
injury, and associated neurological deterioration (44, 45). One 
of the processes that play an important role in secondary brain 
injury is ischemia. Pathological features of ischemic injury are 
present in more than 90% of autopsy specimens from patients 
FiGUre 2 | the effect of a global vasodilatory stimulus on regional blood flow with normal vasculature and with impaired regional vascular 
response. (a) The normal state at normocapnia. The extent of red color in the vascular beds represents actual blood flow and blue color represents potential blood 
flow. “++/++” beside vessels represents normal blood flow at rest (++) compared to the flow demand (++). This would be the case for normal vasculature and for 
vasculature that has branches with reduced vasodilatory capacity. (B) With normal vasculature, hypercapnia stimulates increase blood demand by the vascular 
beds. The vasodilatory demand of the vascular beds combined exceed that of the main feeding vessel (23), which is limiting, i.e., their flow (+++) does not meet 
demand (++++). However, the dilatory response capability of each feeding vessel is symmetrical and so is their flow. (C) In the presence of a dysfunctional vessel, a 
hypercapnic stimulus results in the same demand in the healthy and dysfunctional vessel (i.e., ++++). There is a strong vasodilation in the healthy (upper) branch 
and a weaker vasodilation in the dysfunctional (lower) branch. The inflow from the main vessel is still limiting (i.e., +++/++++). The direct competition for flow 
between the vascular beds results in an increased proportion of the flow through the normal vessel (++++) at the expense of the dysfunctional vessel [flow reduced 
from +++ in (B), to ++]. This is referred to as vascular ‘steal’.
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with fatal TBI (46, 47). Experimental evidence suggests that CBF 
can fall to 50% of baseline levels in patients with severe TBI (48) 
and can remain persistently low for weeks to years after injury 
(49). That this decrease in CBF delivery occurs in the setting 
of increased metabolic need suggests that the pathophysiology 
of TBI may have a neurovascular component. On a smaller 
scale, imbalances in neuronal activity cellular ion transport, 
increased excitatory neurotransmitter release, and impaired 
glucose metabolism coupled with insufficient CBF delivery are 
proposed to account for the “neurometabolic energy crisis” that 
characterizes acute concussion (6, 7). In addition to concussion 
and more severe forms of TBI that can occur in sports- and non-
sports-related activities, blast-related TBI is a unique form of TBI 
that presents with similar symptoms and is also characterized 
by diffuse primary and secondary brain injury processes (50). 
In particular, animal model evidence suggests that blast-related 
TBI is associated with time-dependent alterations in many serum 
proteins responsible for brain cellular metabolic and cerebrovas-
cular processes (51).
Neuroimaging studies in patients with moderate and severe 
TBI have provided important insights into secondary brain injury 
and suggest that alterations in CBF and CVR have an important 
impact on patient outcomes. Bouma et al. (8) found significant 
correlations between low CBF and clinical motor scores and 
functional outcomes following severe TBI using Xe-CT. One-
third of patients exceeded the ischemic stroke CBF threshold 
of <18 ml/100 g/min within 6 h of injury, which was associated 
with higher mortality rates and worse outcomes among survivors. 
Using positron emission tomography (PET)  measurements, 
Coles et  al. (9) found that ischemic brain volumes were sig-
nificantly higher in severe TBI than controls and correlated 
with poor 6-month patient outcomes. Wintermark et  al. (10) 
using perfusion-CT found that low regional CBF following TBI 
was associated with worse 3-month outcomes. Finally, Adelson 
et al. (11), using Xe-CT showed that mean CBF <20 ml/100 g/
min and CVR <2%/mm Hg PaCO2 within 2 days of injury were 
associated with unfavorable outcomes. More recently, Maugans 
et al. (52) demonstrated impaired mean resting CBF in the acute 
phase of pediatric sports-related concussion (SRC) that persisted 
at 1  month despite normalization of neurocognitive testing 
scores. Bartnik-Olson et al. (53) observed reductions in CBF and 
cerebral blood volume in the thalamus of pediatric SRC patients 
compared to normal controls. Meier et al. (54) detected regional 
abnormalities in resting CBF among collegiate SRC patients 
during acute injury that were normalized 1 month later. In this 
latter study, regional CBF within two regions of interest correlated 
with scores on a neuropsychiatric symptom inventory. Finally, 
Wang et al. (55) detected regional reductions in CBF within 24 h 
of injury in collegiate athletes that persisted at day 8 post-injury 
despite normalization of clinical and neurocognitive testing 
scores (for summary, see Table 1).
Overall, evidence from CVR studies in severe TBI and pre-
liminary studies examining resting CBF in SRC patients supports 
the conceptual understanding of concussion as characterized by 
persistent cerebrovascular dysregulation and provides a rationale 
for examining the role of CVR in patients with concussion.
MetHodoLoGiCaL Considerations in 
Mri-Based MeasUreMent oF CVr
Over the past 20 years, advances in neuroimaging technology have 
permitted clinicians and researchers to accurately assess cerebro-
vascular physiology using a number of techniques. At present, 
taBLe 1 | overview of studies examining resting cerebral blood flow in concussion.
reference study population Methodology Clinical concussion 
measures
neuroimaging 
sequence
results
(52) 12 SRC patients (age 
11–15 years) imaged 
<72 h, 14 days, and 
30 days or more post-
injury and 12 control 
subjects
Longitudinal ImPACT ASL and DTI MRI Alterations in mean resting CBF (predominantly reduced 
CBF) in the acute phase of SRC that persisted at 1 month 
despite normalization of neurocognitive testing scores
(53) 15 PCS patients (age 
8–17 years) imaged 
3–12 months post-injury 
and 15 control subjects
Cross-sectional Self-reported 
symptoms
Perfusion-weighted 
and DTI MRI, 
MRI-spectroscopy
PCS group demonstrated reduced CBF and CBV in the 
bilateral thalami compared to the control group. No other 
significant differences in other brain regions
(54) 15 SRC patients (mean 
age = 20.57 years) 
imaged at 0–3 days, 
6–13 days, and 
25–44 days post-injury 
and 27 control subjects
Longitudinal Hamilton Depression 
and Anxiety rating 
scales, ANAM
ASL MRI Reduced CBF in the right dorsal midinsular cortex (dmIC) 
and superior temporal sulcus in SRC group during acute 
phase of injury that were similar to the control group at 
1 month post-injury
Regional blood flow within the dmIC was inversely related 
to the magnitude of initial psychiatric symptoms
(55) 18 SRC patients (mean 
age = 17.8 years) 
imaged within 24 h and 
8 days post-injury and 
19 control subjects
Longitudinal Sport Concussion 
Assessment Tool-
3, Standardized 
Assessment of 
Concussion, Balance 
Error Scoring System, 
ANAM, ImPACT
pCASL MRI At 24 h post-injury reduced CBF was observed in the 
SRC group within the right supplementary motor area 
and pre-supplementary motor areas compared to the 
control group. At 8 days post-injury reduced CBF was 
observed in diffuse cortical gray matter and thalamus in 
the SRC group compared to the control group despite 
normalization of clinical concussion measures
TBI, traumatic brain injury; SRC, sports-related concussion; PCS, postconcussion syndrome; ImPACT, immediate post-concussion assessment and cognitive testing; ASL, arterial 
spin labeling; DTI, diffusion tensor imaging; CBF, cerebral blood flow; ANAM, automated neuropsychological assessment metrics.
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the gold standard for measuring cerebrovascular  parameters 
such as CBF and CMRO2 is PET while single photon emission 
computerized tomography (SPECT) provides comparable assess-
ment of CBF. As previously mentioned, XeCT has also been 
used to measure CVR in previous studies. Unfortunately, such 
approaches employ radiation exposure, intravenous administra-
tion of contrast agents, and occasionally general anesthesia and 
intubation with mechanical ventilation to achieve inspired gas 
control, making these inappropriate techniques for the longitu-
dinal assessment of patients with concussion, especially children 
and adolescents. Transcranial Doppler ultrasonography has also 
been used to measure CVR in normal patients and in various 
cerebrovascular conditions such as concussion (56). It is readily 
available, inexpensive, and non-invasive; however its poor spatial 
resolution for CVR, CBF, and tissue perfusion limit its value.
Because CVR represents the unit change in CBF per unit change 
in a vasoactive stimulus, it is important that both of these variables 
are measured accurately and applied consistently across study sub-
jects. Failure to do so can lead to differences in CVR measurements 
between subjects and subject groups that are due to the methodo-
logical limitations and variability in techniques and not the disease 
processes under investigation. Therefore, in order to provide an 
accurate, reliable, and reproducible MRI-based measure of CVR 
in humans and any patient population an assessment tool must 
combine three essential elements: (1) an MRI sequence that can be 
applied to the entire brain and provide an accurate assessment of 
CBF or its surrogate at high spatial resolution; (2) a standardized 
vasoactive stimulus that can provide a measurable and reproduc-
ible effect on the cerebral vasculature; and (3) a standardized 
method of CVR data analysis that allows comparisons between 
subject groups, and in individual subjects over time.
Cerebral Blood Flow assessment
Among the most common non-invasive MRI sequences that are 
used to assess CBF are blood oxygen level-dependent (BOLD) 
and arterial spin labeling (ASL). BOLD-level MRI is a technique 
that exploits the unique MRI signal characteristics of hemoglobin 
across different oxygenated states within the brain. Simply put, 
changes in CBF within a specific brain region are associated with 
changes in the concentration of hemoglobin that transitions 
between oxygenated and de-oxygenated states within that region. 
This transition is associated with a quantifiable change in the ratio 
between oxyhemoglobin (HbO2) and deoxyhemoglobin (HHb). 
HHb is paramagnetic and degrades the BOLD signal in the vessels 
and surrounding brain tissue. Under normal circumstances, neu-
ronal activation leads to an increase in CBF where the increased 
delivery of oxygen often exceeds the oxygen consumption of the 
surrounding tissue (57) resulting in an increase in the HbO2/HHb 
ratio and a resultant increase in the BOLD signal. Within a limited 
range of CBF, changes in BOLD signal are proportional to reduc-
tions in the concentration of HHb. The relationship between the 
BOLD signal and CBF under a constant CMRO2 is fairly linear 
for CBF increases up to 50% (58), and since CBF changes induced 
during CVR studies are within this magnitude, the BOLD signal 
can be used as a surrogate for CBF measurement. However, 
emerging evidence suggests that the hemodynamic response to 
neuronal activity is a product of a relationship between neuronal 
energy consumption and signaling processes (59–61), CBF, 
6Ellis et al. Neuroimaging Assessment of Cerebrovascular Reactivity in Concussion
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CMRO2, CBV, and hemoglobin concentration. Thus, under 
conditions when brain tissue O2 consumption increases beyond 
normal levels (i.e., during injury), this relationship becomes more 
tenuous.
In contrast, ASL is a technique that can provide a direct 
measurement of CBF within brain tissue. To accomplish this, a 
radiofrequency pulse is applied to label incoming blood water 
protons to invert proton magnetization. These labeled protons 
can be measured once the blood reaches the perfusion bed of 
the target tissue. The balance between labeled intravascular 
water and free water in the tissue is proportionate to the CBF, 
which can then be modeled using post-processing algorithms 
to generate CBF in units of ml/100  g tissue/min (62). This 
technique can be used to measure global and regional resting 
CBF but must be interpreted with caution in the setting of ath-
erosclerotic steno-occlusive disease where damaged or blocked 
vessels can increase transit times, leading to delays in arrival 
of labeled protons and thereby producing errors in the CBF 
measurement. In fact, there are no publications showing the 
efficacy of current ASL techniques for measuring CBF quan-
titatively in patients with advanced cerebrovascular disease. 
At present, PET remains the only accurate method for doing 
so but has lower spatial resolution. Nevertheless, attempts to 
combine ASL with a vasoactive stimulus to measure CVR have 
shown efficacy when assessing limited brain regions (i.e., non-
whole brain coverage) (35). Future refinements of the method 
(delay insensitive whole brain ASL) may eventually lead to 
replacement of BOLD for measurement of CVR in advanced 
cerebrovascular disease.
Taken together, both BOLD and ASL techniques provide 
accurate, reliable, and reproducible measures of whole brain and 
regional CBF and can provide similar measures of CVR if paired 
with a reliable and reproducible vasoactive stimulus.
Vasoactive stimuli
In order to provide an accurate measure of CVR between study 
groups, it is important that assessment tools ensure that subjects 
are exposed to the same magnitude and duration of vasoactive 
stimulus (12). This aim can only be accomplished if the vasoactive 
stimulus produces a quantifiable and reliable effect on the cerebral 
vasculature and if the magnitude of the stimulus can be measured 
at the time of administration. In the case of longitudinal studies, 
it is paramount that the same magnitude of vasoactive stimulus 
is applied and measured on repeat examinations. If the clinician 
or researcher cannot confirm that the same stimulus is applied 
across subjects and during serial assessments within subjects, it 
is impossible to conclude whether the differences in CVR are a 
consequence of changes in the disease process or a function of the 
variability in the study technique (25, 26).
The main vasoactive stimuli that have been used to manipu-
late CBF in CVR studies in stroke and TBI populations fall into 
two categories: (1) injection of an exogenous vasodilatory agent 
(i.e., acetazolamide); (2) modulation of PaCO2 via inhaled CO2, 
breath-holding, or prospective end-tidal targeting. Each of 
these techniques has its own advantages and limitations that 
must be considered in the setting of the patient population 
under study.
Acetazolamide is a carbonic anhydrase inhibitor that produces 
a vasodilatory effect on the cerebral vasculature by inducing an 
intracellular and extracellular acidosis. Since its first introduction 
to measure CVR in 1986 (63, 64), it has been combined with several 
neuroimaging techniques to measure CVR in various cerebrovas-
cular disease populations. While intravenous administration of 
acetzolamide is safe, its side effect profile and effect on CBF are 
unpredictable. In one study, 63% of subjects administered low dose 
acetazolamide developed symptoms such as headaches, nausea, 
dizziness, weakness or numbness of the extremities, and fatigue 
lasting 0.5–72 h that occurred more frequently in younger patients 
and females (65). At higher doses, these side effects can be more 
severe requiring treatment, which in many cases results in prompt 
termination of the study (66, 67). While these symptoms may be 
tolerated in normal control subjects and those with asymptomatic 
cerebrovascular disease, patients with acute SRC and PCS typically 
have many of these symptoms at rest making prolonged exacer-
bation of these symptoms undesirable. The need for intravenous 
access is another disadvantage of this technique, making it less 
appropriate for use in children and adolescents. However, the 
most significant disadvantage of this technique for use in CVR 
studies is the unpredictable pharmacokinetics of acetazolamide 
administration and its resultant effects on CBF. Serum concentra-
tions following intravenous administration have been found to vary 
widely between individuals preventing a reliable stimulus–response 
relationship to be established (12). Even at supramaximal doses, 
acetazolamide does not produce a maximal CBF response in many 
normal subjects (66, 67) and can continue to be modulated by the 
effects of respiratory rate and blood pressure during neuroimaging 
acquisition. Although some studies have demonstrated that CVR 
measurements using acetazolamide are comparable to studies 
using inspired CO2 and breath-holding techniques (68–70), they 
are not reliably so, and there are other techniques that provide a 
better tolerated and more reliable vasoactive stimulus.
PaCO2 is the most potent stimulus for cerebral vasculature 
vasodilation whereby each millimeter of mercury unit increase 
is associated by a 2–15% increase in CBF (71, 72). Increases in 
PETCO2 levels of 5–10 mmHg are commonly experienced among 
children and adults during sleep and physical activities and are 
well tolerated during studies targeting these levels (73). While 
administering a fixed “dose” of inspired CO2 makes intuitive sense, 
the PaCO2 is not simply a function of the inspired PCO2. Rather, it 
is also a function of the ventilatory response, which is a function of 
the individual CO2 sensitivity that varies between subjects, as will 
the PetCO2 in response to fixed inspired PCO2. Since the subject’s 
ventilatory response cannot be restrained or predicted, neither 
can the PaCO2 (74). Furthermore, the PaCO2 (the actual stimulus) 
is not reliably known as it is loosely related to PetCO2 (what is 
measured), thus reducing the signal-to-noise ratio (SNR) for CVR 
measurement. Hyperventilation during a hypercapnic challenge 
can also lead to increases in end-tidal O2 (PETO2) and PaO2 (up to 
15 mmHg) (75), which can result in an increase in BOLD signal 
that is independent of the PaCO2 changes leading to falsely elevated 
CVR values (76). Furthermore, the BP response to CO2 can also 
vary considerably among normal control subjects and can act as an 
additional confounding variable for accurate CVR measurement 
(29). Altogether, there are numerous individual differences that 
FiGUre 3 | Block design breathing protocol using model-based prospective end-tidal etCo2 and eto2 targeting. Triple hypercapnic stimulus during 
controlled iso-oxic conditions is illustrated. Breath-by-breath confirmation of ETCO2 and ETO2 allows for accurate measurement and interpretation of CVR 
assessments.
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influence CVR measurement; factors that are difficult to account 
for unless PetCO2 PetO2, HR, BP, and ventilatory rate are rigor-
ously and frequently measured during image acquisition.
For those studies that use block design CO2 breathing proto-
cols, the rates of change of PaCO2 and PaO2, are unpredictable, 
other than knowing that no plateau is likely to be achieved within 
the duration of a protocol. Because CVR represents the change in 
CBF per unit change in CO2, some studies have used PetCO2 as 
a surrogate for PaCO2. However, the differences between PetCO2 
and PaCO2 depend on a number of factors including age, exercise, 
body composition, and other features of respiratory physiology. 
Even under conditions of accurate and frequent PetCO2 and 
PetO2 measurement, CO2 inhalation generates an imprecise 
vasoactive stimulus and therefore an imprecise measure of CVR.
Another technique that has been long used to generate a 
hypercapnic stimulus in CVR studies is breath holding. The 
primary advantage of this technique is it requires no breathing 
circuits or equipment to administer CO2. A simplifying assump-
tion is that breath-holding results in a linear rise in PaCO2 with 
time. In this way, the magnitude of the vasoactive stimulus is con-
ceptually quantified according to the duration of breath-holding. 
However, the rise of PaCO2 with time is not linear; the tolerance 
for duration of breath-holding varies widely between people 
(68); the PaO2 drops precipitously with time; and the PetCO2 at 
the end of breath-holding is not necessarily equal to the PaCO2. 
Consequently, there is no consensus on how breath-holding 
data should be analyzed as there is no stimulus information 
(no knowledge of PaCO2 levels) and selection of an appropri-
ate regressor to regress against the BOLD data for generation 
of global CVR maps is problematic. Finally, as breath-holding 
relies on repeated sustained Valsalva maneuvers, it is undesirable 
for use in patients with acute SRC and PCS who, in our clinical 
experience, frequently report an exacerbation of their concussion 
symptoms with this type of exertion.
Among currently available techniques, only automated com-
puter controlled gas blenders have proved capable of delivering a 
precise, highly controlled, and measurable hypercapnic stimulus 
for CVR studies (75, 77). These techniques are capable of precise 
manipulation of PetCO2 under iso-oxic conditions. In this way, 
the CBF changes that result from changes in PaCO2 are not 
adversely effected by the unaccounted changes in PaO2. They also 
enable various patterns of gas challenges with transitions such as 
a step change, ramp, or multi-block design that can be tailored to 
the patient population and permit statistically rigorous assessment 
of CVR (24, 25, 71, 78). The prospective targeting method includes 
end-inspiratory rebreathing assuring the equality of the PetCO2 
and PaCO2 (79, 80) and providing the same vasoactive stimulus in 
comparative and longitudinal studies; an important requirement 
that can not be met by other techniques previously described here 
(26) (an example of prospective end-tidal targeting is provided in 
Figure 3). Prospective targeting is safe (all inspired gases contain 
O2) and well tolerated and requires only a minimal amount of coop-
eration on the part of study subjects. Using this technique, children 
as young as 10 years of age with cerebrovascular disease (81) and 
as young as 13 years of age with concussion (17) have undergone 
successful CVR imaging. Most importantly, the rigorous control of 
end-tidal gases permitted by this technique translates into precise 
voxel tracking during BOLD image acquisition and highly reli-
able and reproducible between (22) and within-subject measures 
of CVR (26, 73). This level of performance however comes with 
FiGUre 4 | second-level analysis maps and postconcussion symptom scale scores for healthy control subject and adolescent postconcussion 
syndrome patient. Second level individual comparisons examined at the p = 0.005 level demonstrate no evidence of abnormal voxels in the healthy control subject 
compared to the atlas of normal controls (left panel). Quantitative patient-specific alterations in cerebrovascular responsiveness are demonstrated in the adolescent 
postconcussion syndrome patient (right panel).
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some disadvantages compared to other techniques including the 
need for specialized equipment including the breathing circuits, 
gas blender, and customized gases as well as the need for on-site 
personnel that have experience in respiratory physiology and 
mechanics and are trained to operate the equipment.
When compared, both inhaled CO2 and breath-holding have 
been found to provide an inferior assessment of absolute CVR 
compared to prospective targeting (82). Although associated 
with an increased investment in cost and personnel, prospective 
targeting is the only available technique capable of providing an 
accurate, reliable, and reproducible vasoactive stimulus and thus 
optimal assessment of CVR.
data analysis
The primary goal of CVR data analysis is to assess whether global or 
regional differences in CVR observed among a patient or a group 
of patients are significantly different compared to those observed 
among healthy control subjects and that the characteristics of the 
disease under investigation are responsible for this difference. 
Because of the wide variability in structural brain characteristics 
and CVR values that can occur in healthy subjects, it is impor-
tant that CVR data analysis techniques provide a standardized 
method of subject comparison that control for these subtleties. 
Accomplishing this aim requires the generation of a sizeable 
normal control atlas that can account for the immaterial variables 
that can potentially contribute to changes in CVR including age, 
sex, hemoglobin concentration, physical fitness level, time of day, 
hormone levels, state of mind, and technical factors related to the 
vasoactive stimulus and MRI equipment (25). Importantly, as it 
relates to concussion, it is also necessary that the control atlas 
include patients with a history of previous but recovered concus-
sion so that observed changes in CVR can be reliably attributed 
to the most recent and symptomatic concussion and not just the 
presence of any lifetime concussion. At present, there are several 
CVR data analysis techniques that can be used to facilitate these 
comparisons.
FiGUre 5 | Longitudinal assessment of healthy control subject. Second-level analysis in a healthy adolescent imaged 18 months apart and compared to a 
normal atlas reveals stable CVR assessment. The p-value is 0.005 as in Figure 4.
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A detailed description of the application of such a technique 
has been described by Sobczyk et  al. (25). A reference atlas is 
constructed using Analysis of Functional NeuroImages (AFNI) 
software to co-register each of the individual T1-weighted ana-
tomical images into a common Montreal Neurological Institute 
152 space (MNI152) using a calculated transformation subse-
quently applied to the BOLD data. In order to generate a CVR 
reference atlas, each healthy subject’s anatomical and BOLD data 
(whether normal control or patient) are normalized into the same 
MNI152 space and time aligned with PetCO2 allowing CVR to 
be calculated for each voxel. The mean (M) ± SD of CVR for each 
voxel location is calculated. In a test scan, the CVR of the corre-
sponding voxel is scored according to its z score [z = (M − CVR)/
SD] by comparison to the reference atlas. This normalizes the 
voxel CVR score for anatomical location and provides a prob-
ability score of its being within the normal range. The magnitude 
of the z score (larger numbers implying low probabilities of being 
normal) is color-coded and superimposed onto the subject’s ana-
tomic scan providing a comprehensive view of the distribution of 
normal and abnormal responses in the scan. This CVR scoring 
technique therefore takes into account the voxel’s anatomical 
location as well as the normal variability. It would be particularly 
important for the study of concussion, where the injury may be 
diffuse or isolated in particular anatomical regions.
A second technique described by Mutch et al. (14, 17, 71) uses 
a similar methodology. In this technique, anatomical and BOLD 
data from the normal control subjects are post-processed using 
SPM, normalized into MNI152 space and time-aligned with the 
PetCO2 output to generate a normal CVR atlas. To assess voxel-
by-voxel differences in the CVR response between an individual 
subject (control or patient), second-level analyses can be com-
pleted under conditions that examine the number of voxels that 
are greater than or less than those observed in the control atlas 
with different levels of statistical significance. In this way, voxel-
by-voxel differences can be color coded and overlaid onto the 
anatomical maps to provide a qualitative assessment of regional 
CVR abnormalities (Figure  4). More importantly, quantitative 
biomarkers for voxels greater than, less than, or the sum of these 
(total abnormal voxel counts) can be generated and compared 
to other objective measures of the condition under investigation. 
FiGUre 6 | Longitudinal assessment of adolescent postconcussion syndrome patient. Symptomatic adolescent PCS patient imaged following abnormal 
formal neuropsychological testing and symptom-limiting threshold on graded aerobic treadmill testing 3 months post-injury [left panel; image reproduced with 
permission from Journal of Neurosurgery [Mutch et al. (17)]. Patient re-imaged 5 months later following treatment with sub-maximal exercise prescription resulting in 
symptom, neuropsychological, and physiological recovery (right panel). The p-value is 0.005 as in Figures 4 and 5.
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Similar to the z-scores described above, these quantitative bio-
markers can be used to longitudinally track CVR abnormalities 
over time in individual subjects or patients (Figures 5 and 6).
In addition to evaluating global and regional voxel-wise dif-
ferences in CVR between normal control subjects and patients, 
additional modifications to these techniques can be used to 
measure the rate of CBF increase to a controlled vasoactive stimu-
lus. Using the prospective targeting approach for CO2 delivery, 
subjects undergo an abrupt (within two breaths) step change in 
PetCO2 during BOLD imaging acquisition (24). Analysis can 
then proceed by one of two methods. First, both the steady state 
CVR and the rate of change of the BOLD response (expressed as 
a time constant of change for an exponential function or tau) can 
be calculated on a voxel-by-voxel basis. These measurements can 
be color-coded similar to the raw CVR data and overlaid onto 
the subject’s anatomical maps to generate tau and steady state 
CVR maps that can be analyzed in a fashion analogous to the 
z-map technique (24). Second, transfer function analysis can also 
be applied, which provides even greater information about the 
dynamic BOLD response to hypercapnia including gain, coher-
ence, and phase (78). Preliminary studies suggest that the onset 
and time course of the CBF response to a vasodilatory stimulus 
is prolonged in patients with other cerebrovascular diseases such 
as steno-occlusive disease and Alzheimer’s disease (24, 78). To 
date, there have been no studies that have examined the dynamic 
BOLD response to a vasodilatory stimulus in TBI or concussion.
oVerVieW oF CVr stUdies in 
ConCUssion
The preceding discussion of cerebrovascular pathophysiology in 
TBI, and CVR measurement techniques, provides a perspective from 
which to evaluate the quality and applicability of previous (and future) 
studies that examine CVR in patients with concussion (Table 2).
We searched for published studies that met the following 
criteria: (1) included a study population of one or more patients 
with concussion or mTBI and (2) utilized MRI-based techniques 
to measure CVR or cerebrovascular responsiveness. Overall, four 
taBLe 2 | Methodological framework for evaluation of cerebrovascular 
reactivity measurement in concussion.
Questions
(1) What is the patient population being investigated (e.g., acute 
concussion, sports-related concussion, postconcussion syndrome, 
mTBI)?
(2) What is the study methodology (e.g., cross-sectional and longitudinal)?
(3) What clinical measures are used to assess concussion patients (e.g., 
symptom inventory, neurocognitive tests)?
(4) Are the control group subjects appropriate for comparison to the patient 
population?
(5) What neuroimaging sequences are used to assess cerebral blood flow 
(e.g., BOLD MRI, and ASL)?
(6) What vasoactive stimulus is used to manipulate cerebral blood flow?
(7) Is the magnitude of the vasoactive stimulus measured and reported?
(8) Is the magnitude of the vasoactive stimulus equal between groups and 
within subjects?
(9) What are the results of CVR measurement (e.g., group differences and 
individual differences)?
(10) Does the CVR assessment technique yield any quantitative biomarkers?
(11) What is the relationship between the CVR results and other 
neuroimaging findings?
mTBI, mild traumatic brain injury; BOLD, blood oxygen-dependent level; ASL, arterial 
spin labeling; CVR, cerebrovascular reactivity.
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studies met the inclusion criteria and were analyzed (results sum-
marized in Table 3).
Among these, Mutch et  al. (14) utilized prospective iso-oxic 
targeting of PetCO2 and BOLD MRI to examine cerebrovascular 
responsiveness in adult concussion patients and normal control 
subjects. In this pilot study, they observed no differences in 
PetCO2 changes and whole brain CVR between subject groups. 
However, they demonstrated quantified patient-specific altera-
tions in CVR that were present in both symptomatic and asympto-
matic concussion patients that were absent among healthy control 
subjects. Chan et  al. (15) performed a longitudinal study on a 
single mTBI patient during the symptomatic and asymptomatic 
stages of mTBI. Using breath-holding during BOLD MRI, they 
observed qualitative asymmetries in whole brain CVR on the 
initial assessment that were less asymmetrical on follow-up assess-
ment. Miltana et al. (16) used inhaled CO2 during BOLD MRI to 
evaluate CVR in a group of acute SRC patients and healthy control 
subjects. They observed CVR values within certain regions of 
interest that were higher in the SRC group compared to the control 
group. Increased functional connectivity within the hippocampus 
correlated with increased CVR values. No group differences were 
observed in resting mean CBF measured with pCASL. Finally, 
Mutch et  al. (17) utilized prospective PetCO2 and BOLD MRI 
to examine cerebrovascular responsiveness in adolescent PCS 
patients and normal controls. With a standardized PetCO2, there 
was a reduced cerebrovascular responsiveness observed in the 
PCS group. Patient-specific qualitative and quantitative alterations 
in cerebrovascular responsiveness were observed in all individual 
PCS patients. Preliminary receiver operator curve analysis revealed 
an area under the curve of 0.87 (p < 0.0001) for voxels manifest-
ing a CVR response greater than the control response and 0.80 
(p = 0.0003) for those manifesting a CVR response lower than the 
control response. No differences in global mean CBF measured 
with pCASL were observed; however, patient-specific alterations 
in regional resting CBF were observed among PCS patients.
CoMMents
Although recent neuroimaging studies have advanced our 
understanding of concussion and mTBI, a diagnostic assessment 
tool that provides qualitative and quantitative assessment of brain 
pathophysiology in this clinical population has remained elusive. 
Despite the increasing popularity and application of neuroimag-
ing tools such as diffusion tensor imaging, task-based and resting 
state functional MRI, and MRI-based assessment of resting CBF 
in the academic literature, none of these techniques are presently 
capable of providing clinically meaningful information that 
impacts the management of individual concussion patients (83, 
84). However, in its relatively short history, MRI-based CVR 
imaging has the potential to play an instrumental role in the 
diagnosis, prognostication, and management of several cerebro-
vascular disorders. Because TBI and concussion are thought to be 
associated with alterations in cellular metabolism and CBF that 
are similar to those observed in stroke, the emerging concept 
of concussion as a form of cerebrovascular disease is novel and 
intriguing. Consequently, there is hope that MRI-based CBF 
and CVR studies will not only uncover the pathophysiological 
mechanisms governing individual concussion symptoms but 
may also provide a means to accurately and reliably contribute 
to the diagnosis, classification, prognostication, and confirmed 
recovery in individual acute concussion and PCS patients.
As future studies venture into this evolving landscape, it 
is important for clinicians and researchers to have a thorough 
appreciation of the role of CBF and CVR in TBI, and have an 
understanding of the methodological limitations of the neu-
roimaging assessment tools that are used to investigate these 
processes. As discussed here, currently available MRI sequences 
provide an accurate, reliable, and reproducible measure of CBF. 
Unfortunately, the vasoactive stimuli used to manipulate CBF, 
and therefore, permit accurate measurement of CVR are not 
methodologically equal. Readers are reminded that in order to 
provide accurate, reliable, and reproducible measures of CVR 
that the magnitude of the vasoactive stimulus must be measur-
able and equal across subjects, otherwise conclusions regarding 
the effects of a disease process on cerebrovascular physiology 
can not be reliably made. This issue is sufficient to account for 
the paucity of reliable and comparable data regarding the role of 
cerebrovascular dysfunction in concussion, to date.
For MRI-based CVR assessment to impact the management 
of individual concussion patients, a number of unique challenges 
must be overcome. Unlike cerebrovascular diseases such as stroke 
which have well validated neuroimaging and clinical outcome 
measures against which CVR findings can be compared, the 
severity of concussion and its effect on subjective physical, cog-
nitive, and emotional functioning are not easily measured. Many 
of the symptoms of concussion are non-specific and found in 
other conditions such as primary headache disorders, whiplash, 
depression, and endorsed among normal subjects in the absence 
of TBI (85–90). Although neurocognitive and neuropsychiatric 
tools can provide an objective measure of some of these processes, 
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there remain a significant proportion of concussion patients in 
whom these studies are normal despite ongoing symptoms. Not 
only does this reinforce the need to apply a multi-disciplinary 
approach to concussion diagnosis and recovery assessment but 
also suggests that neuroimaging studies that generate potential 
quantitative biomarkers that rely on an association with scores 
based on other objective tools such as these must be interpreted 
with caution and may not be generalizable to broader acute 
concussion and PCS populations. Most importantly, because 
patients with concussion may have pre-existing conditions or 
develop neurological complications or disorders such as depres-
sion, migraine headaches, and other neurodegenerative diseases 
such as chronic traumatic encephalopathy that may also have a 
cerebrovascular etiology, the potential for using this technology 
as a diagnostic and medical clearance tool will rely on its ability 
to reliably distinguish between concussion and these pre-existing 
and post-injury disorders. Given the enormity of factors that 
influence CVR in normal healthy subjects and the likelihood 
that the alterations in CVR that occur in concussion are much 
more subtle than those that characterize other cerebrovascular 
disease, at present, the availability of a precise reproducible 
vasoactive stimulus reduces the SNR optimizing the opportunity 
to identify the cerebrovascular biomarkers associated with this 
condition.
In summary, preliminary research suggests that concussion 
is a heterogeneous condition that presents with patient-specific 
alterations in cerebrovascular physiology that can be safely and 
reliably assessed using validated MRI-based CBF and CVR 
assessment techniques. Future studies are warranted to determine 
the magnitude and natural history of these alterations following 
acute concussion, their relationship to other objective concussion 
assessment tools, and whether these alterations can be amelio-
rated through the application of targeted rehabilitation strategies.
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